Ayda Mayer PhD

Ayda Mayer is the Executive Director of Vector Core at REGENXBIO, a leading AAV gene therapy company, supporting the company’s broad pipeline of investigational AAV Therapeutics for rare and common conditions. In her role, she leads the efforts on high-throughput vector production, and early phase process and technology development, including cell lines and expression systems. Prior to joining REGENXBIO, Ayda was the Head of Cell Culture Sciences at MacroGenics.

Earlier in her career, she led the Process Development team at Aeras and served as Director of Microbial and Cell Culture Development at GlaxoSmithKline and Human Genome Sciences in Biopharmaceutical Development, gaining expertise from the early phase to commercialization of recombinant proteins and monoclonal antibodies. Ayda has a Ph.D. in Biochemical Engineering focusing on renewable resources from Purdue University.